
Panelists challenge the belief that testosterone fuels prostate cancer, explain PSA on therapy and TRAVERSE BPH data, and weigh Schedule III status.
Rochester, MN-When Mayo Clinic researchers recently reported a link between nonsteroidal anti-inflammatory drugs (NSAIDs) and a reduced incidence of prostate cancer, it simply confirmed what many in the field already suspected.





